Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 27 | 2026 | 28 | 3.020 |
Why?
|
| Thioredoxin-Disulfide Reductase | 9 | 2026 | 9 | 1.750 |
Why?
|
| Enzyme Inhibitors | 10 | 2026 | 51 | 1.460 |
Why?
|
| NADH, NADPH Oxidoreductases | 13 | 2026 | 13 | 1.240 |
Why?
|
| Multienzyme Complexes | 13 | 2026 | 16 | 1.240 |
Why?
|
| Cryptosporidium parvum | 2 | 2026 | 2 | 1.140 |
Why?
|
| Animals | 41 | 2026 | 1349 | 1.110 |
Why?
|
| Cryptosporidium | 1 | 2025 | 1 | 0.900 |
Why?
|
| Protozoan Proteins | 1 | 2025 | 1 | 0.900 |
Why?
|
| Antimalarials | 5 | 2026 | 9 | 0.850 |
Why?
|
| Oxidation-Reduction | 10 | 2026 | 21 | 0.790 |
Why?
|
| Schistosomiasis mansoni | 9 | 2022 | 10 | 0.720 |
Why?
|
| Auranofin | 6 | 2025 | 6 | 0.640 |
Why?
|
| Peroxiredoxins | 8 | 2021 | 8 | 0.620 |
Why?
|
| Naphthoquinones | 4 | 2024 | 4 | 0.620 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 48 | 0.600 |
Why?
|
| Schistosomicides | 5 | 2026 | 5 | 0.600 |
Why?
|
| NADP | 4 | 2024 | 7 | 0.500 |
Why?
|
| Gold | 3 | 2026 | 3 | 0.500 |
Why?
|
| Humans | 24 | 2026 | 5837 | 0.490 |
Why?
|
| Mice | 12 | 2026 | 465 | 0.480 |
Why?
|
| Anthelmintics | 4 | 2020 | 6 | 0.480 |
Why?
|
| Models, Molecular | 7 | 2026 | 24 | 0.470 |
Why?
|
| Schistosomiasis | 3 | 2023 | 4 | 0.460 |
Why?
|
| Thioredoxin Reductase 1 | 2 | 2025 | 2 | 0.450 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 7 | 0.450 |
Why?
|
| Hypertension, Pulmonary | 2 | 2026 | 7 | 0.440 |
Why?
|
| Plasmodium falciparum | 4 | 2026 | 4 | 0.430 |
Why?
|
| Crystallography, X-Ray | 7 | 2026 | 9 | 0.430 |
Why?
|
| Peroxidases | 2 | 2006 | 3 | 0.400 |
Why?
|
| Coordination Complexes | 2 | 2026 | 2 | 0.400 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 34 | 0.400 |
Why?
|
| Oxidative Stress | 4 | 2025 | 25 | 0.330 |
Why?
|
| Glutathione | 4 | 2025 | 9 | 0.300 |
Why?
|
| Thioredoxins | 3 | 2025 | 3 | 0.290 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 51 | 0.290 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2019 | 10 | 0.270 |
Why?
|
| Glutathione Reductase | 3 | 2019 | 3 | 0.260 |
Why?
|
| Amino Acid Sequence | 10 | 2013 | 46 | 0.260 |
Why?
|
| Female | 10 | 2026 | 3346 | 0.250 |
Why?
|
| Ancylostoma | 2 | 2019 | 2 | 0.250 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2026 | 2 | 0.240 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2026 | 2 | 0.240 |
Why?
|
| Xanthones | 1 | 2026 | 1 | 0.240 |
Why?
|
| Organogold Compounds | 1 | 2026 | 1 | 0.240 |
Why?
|
| Albumins | 1 | 2006 | 2 | 0.240 |
Why?
|
| Mefloquine | 1 | 2026 | 1 | 0.240 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2025 | 1 | 0.240 |
Why?
|
| Inflammation | 1 | 2026 | 53 | 0.230 |
Why?
|
| Antiparasitic Agents | 2 | 2024 | 2 | 0.230 |
Why?
|
| Cryptosporidiosis | 1 | 2025 | 1 | 0.230 |
Why?
|
| Prodrugs | 1 | 2024 | 1 | 0.220 |
Why?
|
| Antigens, Helminth | 2 | 2003 | 2 | 0.220 |
Why?
|
| Malaria, Falciparum | 2 | 2013 | 2 | 0.220 |
Why?
|
| Brugia malayi | 2 | 2022 | 2 | 0.210 |
Why?
|
| Onchocerca volvulus | 2 | 2022 | 2 | 0.210 |
Why?
|
| Structure-Activity Relationship | 6 | 2026 | 16 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 24 | 0.200 |
Why?
|
| Drug Design | 1 | 2013 | 4 | 0.190 |
Why?
|
| Cysteine | 4 | 2022 | 4 | 0.190 |
Why?
|
| Oxadiazoles | 2 | 2014 | 3 | 0.180 |
Why?
|
| Parasites | 1 | 2022 | 1 | 0.180 |
Why?
|
| Plants, Medicinal | 1 | 2022 | 2 | 0.180 |
Why?
|
| Biological Products | 1 | 2022 | 9 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2003 | 17 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 63 | 0.180 |
Why?
|
| Glutathione Peroxidase | 3 | 2006 | 5 | 0.180 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.170 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 13 | 0.170 |
Why?
|
| Nanostructures | 1 | 2021 | 5 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 26 | 0.170 |
Why?
|
| Helminthiasis | 1 | 2020 | 1 | 0.170 |
Why?
|
| Protozoan Infections | 1 | 2020 | 1 | 0.170 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 3 | 0.160 |
Why?
|
| Proteins | 1 | 2021 | 22 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 13 | 0.160 |
Why?
|
| Neoplasms | 1 | 2020 | 39 | 0.160 |
Why?
|
| Molecular Structure | 4 | 2024 | 6 | 0.150 |
Why?
|
| Male | 6 | 2026 | 3399 | 0.150 |
Why?
|
| Oviposition | 1 | 2019 | 1 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 1 | 0.150 |
Why?
|
| Helminth Proteins | 2 | 2009 | 2 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 66 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2013 | 25 | 0.130 |
Why?
|
| Nitric Oxide Donors | 2 | 2014 | 6 | 0.130 |
Why?
|
| Computational Biology | 3 | 2012 | 7 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2014 | 24 | 0.130 |
Why?
|
| Apoptosis | 2 | 2026 | 65 | 0.120 |
Why?
|
| Hydrogen Peroxide | 3 | 2008 | 12 | 0.120 |
Why?
|
| Base Sequence | 6 | 2006 | 36 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 8 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2015 | 1 | 0.110 |
Why?
|
| Erythrocytes | 1 | 2015 | 8 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2025 | 43 | 0.110 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 1 | 0.110 |
Why?
|
| Loiasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Microfilariae | 1 | 2015 | 1 | 0.110 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2026 | 16 | 0.110 |
Why?
|
| Lung | 2 | 2026 | 31 | 0.110 |
Why?
|
| Praziquantel | 1 | 2014 | 2 | 0.110 |
Why?
|
| Isoquinolines | 1 | 2014 | 5 | 0.110 |
Why?
|
| Pyrazines | 1 | 2014 | 6 | 0.110 |
Why?
|
| S-Nitrosothiols | 1 | 2014 | 1 | 0.100 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 1 | 0.100 |
Why?
|
| Disulfides | 1 | 2014 | 2 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 10 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2012 | 11 | 0.100 |
Why?
|
| Ancylostomiasis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2013 | 2 | 0.100 |
Why?
|
| Genome, Helminth | 2 | 2012 | 2 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 14 | 0.090 |
Why?
|
| Quinolines | 1 | 2012 | 2 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 2 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 24 | 0.090 |
Why?
|
| Cell Line | 3 | 2015 | 72 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2026 | 103 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2008 | 64 | 0.080 |
Why?
|
| DNA, Helminth | 3 | 2012 | 3 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 17 | 0.070 |
Why?
|
| DNA | 4 | 2009 | 38 | 0.070 |
Why?
|
| Biomphalaria | 1 | 2009 | 1 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 222 | 0.070 |
Why?
|
| Fasciola hepatica | 1 | 2008 | 1 | 0.070 |
Why?
|
| Fascioliasis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2008 | 1 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 4 | 0.070 |
Why?
|
| Macrophages | 1 | 2008 | 21 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 24 | 0.070 |
Why?
|
| Catalysis | 2 | 2013 | 8 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 1 | 0.060 |
Why?
|
| Palladium | 1 | 2026 | 1 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 22 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 23 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 32 | 0.060 |
Why?
|
| Cycloaddition Reaction | 1 | 2024 | 1 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2024 | 2 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2024 | 7 | 0.050 |
Why?
|
| Drug Discovery | 2 | 2018 | 3 | 0.050 |
Why?
|
| Phylogeny | 3 | 2012 | 14 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 1 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 5 | 0.050 |
Why?
|
| Retroelements | 1 | 2003 | 1 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 2 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cloning, Molecular | 4 | 2000 | 10 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2022 | 1 | 0.050 |
Why?
|
| Kenya | 1 | 2022 | 2 | 0.050 |
Why?
|
| Herbal Medicine | 1 | 2022 | 2 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 8 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 36 | 0.050 |
Why?
|
| Genes, Helminth | 2 | 2009 | 2 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 110 | 0.040 |
Why?
|
| Solubility | 2 | 2012 | 5 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2001 | 7 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2001 | 8 | 0.040 |
Why?
|
| Biopolymers | 1 | 2021 | 3 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2009 | 3 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2020 | 4 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 71 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 1 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 3 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2000 | 8 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 35 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 122 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 1 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 2 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 75 | 0.040 |
Why?
|
| Electrochemistry | 1 | 2015 | 17 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 86 | 0.030 |
Why?
|
| Acetylglucosaminidase | 1 | 1995 | 1 | 0.030 |
Why?
|
| Chitinases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Hexosaminidases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Streptomyces | 1 | 1995 | 1 | 0.030 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 1 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Malaria | 1 | 2015 | 2 | 0.030 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 2 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 2 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1994 | 4 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1994 | 14 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1994 | 23 | 0.030 |
Why?
|
| Nitrosation | 1 | 2014 | 1 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 8 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 2 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 2 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 90 | 0.020 |
Why?
|
| Hemin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Methemoglobin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 9 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 2 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 5 | 0.020 |
Why?
|
| Selenocysteine | 1 | 2011 | 1 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 9 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Schistosoma | 1 | 2009 | 1 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 4 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 4 | 0.020 |
Why?
|
| Selenium | 1 | 2009 | 1 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 11 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2009 | 1 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 1 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2009 | 2 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 7 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 6 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 282 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 2 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 6 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 167 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 139 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 26 | 0.010 |
Why?
|
| Genomic Library | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 1 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 13 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 24 | 0.010 |
Why?
|
| Parasite Egg Count | 1 | 2003 | 1 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 16 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 44 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 488 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2000 | 1 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 2 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 4 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 4 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 7 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 1775 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 46 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 14 | 0.010 |
Why?
|
| RNA | 1 | 1994 | 10 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 1994 | 1 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 2 | 0.010 |
Why?
|